It is a thoughtful option for patients looking to complement their skincare, aesthetic treatments, and wellness routine with a more inside-out approach
Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss
When using semaglutide for weight loss , studies show that patients typically experience a gradual reduction in body weight
This episode digs deep into the science behind sleep, helping you discover the root cause of middle-of-the-night disturbances & finally feel good in the morning
The switching from tirzepatide to retatrutide guide covers the newer option
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes